Welcome to our dedicated page for Sopra Steria news (Ticker: SPPSY), a resource for investors and traders seeking the latest updates and insights on Sopra Steria stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Sopra Steria's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Sopra Steria's position in the market.
Summary not available.
Summary not available.
Summary not available.
Ordina and Sopra Steria jointly announced an update on their intended public offer for all ordinary shares in Ordina. This follows a prior announcement of a cash offer at EUR 5.75 per share. The companies are progressing well in preparing the Offer Memorandum, which is expected to be submitted to the Dutch Authority for the Financial Markets by the end of May 2023. They also seek clearance from the European Commission, with expectations to secure it in line with the Offer timetable. Furthermore, Sopra Steria confirmed it can fully fund the offer through its cash resources and an undrawn EUR 1.1 billion Revolving Credit Facility. The Offer is anticipated to close in the second half of 2023.
Sopra Steria Group announced the total number of shares and voting rights in compliance with the French Commercial Code. As of 27 March 2023, the company has a total of 20,547,701 shares. The theoretical number of voting rights stands at 26,508,198, while 26,289,275 voting rights can be exercised. This information comes ahead of the general meeting scheduled for 24 May 2023.
Sopra Steria Group has reported its share and voting rights figures as of March 31, 2023, adhering to French regulatory requirements. The total number of shares is 20,547,701, with a theoretical number of voting rights reaching 26,506,454. The number of voting rights that can be exercised stands at 26,291,654. This information is provided in line with the stipulations of the French Commercial Code and the regulations of the French financial markets authority.
For more details, the original French press release serves as the binding text in case of discrepancies in interpretation.
Summary not available.
Sopra Steria has reached a conditional agreement for an all-cash public offer for Ordina shares at EUR 5.75 each, marking a 36% premium over the March 14 closing price and a total valuation of approximately EUR 518 million. The deal aims to strengthen Sopra Steria's position in the BeNeLux IT consulting market, enhancing digital capabilities and operational efficiency. Ordina's CEO will lead the combined operations, with expectations of EPS accretion of +1.2% in 2024 and +3.7% in 2025. Support from Ordina's major shareholders and management is confirmed, with the transaction expected to be completed by Q4 2023.
Summary not available.
2022 Universal Registration Document Annual Financial Report was registered with the Autorité des Marchés Financiers on
The document serves as a key resource for understanding Sopra Steria's performance and plans within the financial year.